ALTRAZ TABLET

Altraz Tablet is an anastrozole-based medication primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It works by lowering estrogen levels in the body, which helps slow or stop the growth of certain types of breast cancer cells that depend on estrogen. Altraz Tablet is commonly prescribed as part of long-term hormone therapy under medical supervision.

This tablet belongs to a class of medicines known as aromatase inhibitors. By blocking the aromatase enzyme, the Altraz Tablet reduces estrogen production, helping prevent cancer recurrence and supporting effective disease management. It is widely used in oncology treatment plans either as initial therapy or following other cancer treatments, depending on the patient’s condition and the doctor’s recommendation.

Altraz Tablet is produced and supplied in compliance with established quality standards to ensure safety, consistency, and reliable therapeutic performance. Proper storage and adherence to the prescribed dosage help maintain its effectiveness. It is regarded as one of the trusted products in the pharmaceutical sector for hormone-based breast cancer management.

Product Features

• Contains Anastrozole formulation
• Used in hormone receptor-positive breast cancer
• Reduces estrogen production effectively
• Belongs to the aromatase inhibitor class
• Administered under the oncologist’s supervision

How It Helps

• Lowers estrogen levels in the body
• Slows the growth of hormone-dependent cancer cells
• Reduces risk of cancer recurrence
• Supports long-term breast cancer management